World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
28222
World Ranking
1869
National Ranking
74

Medicine

D-Index
76
Citations
28237
World Ranking
18648
National Ranking
688

Elisabeth H. Bel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elisabeth H. Bel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elisabeth H. Bel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elisabeth H. Bel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2018 - Member of Academia Europaea

Overview

Elisabeth H. Bel is affiliated with the University of Amsterdam in the Netherlands and focuses on research in the field of medicine, with a particular emphasis on pulmonary and respiratory medicine, physiology, surgery, immunology, and immunology and allergy. Their scholarly work spans multiple aspects of respiratory diseases and related therapies.

The researcher's prominent topics of study include:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Eosinophilic esophagitis
  • Inhalation and respiratory drug delivery
  • IL-33, ST2, and ILC pathways
  • Allergic rhinitis and sensitization
  • Chronic obstructive pulmonary disease (COPD) research

Frequent collaborators in their research include Anneke Ten Brinke, Katrien Eger, Peter Howarth, Ratko Djukanović, and Simone Hashimoto. These coauthors have contributed consistently, indicating sustained scientific partnerships.

Their publications appear regularly in notable venues, including:

  • ERJ Open Research
  • The Journal of Allergy and Clinical Immunology In Practice
  • European Respiratory Journal
  • Allergy
  • Respiratory Medicine

Selected recent papers include:

  • Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life Evaluation, 2020, The Journal of Allergy and Clinical Immunology In Practice
  • Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study, 2021, The Lancet Respiratory Medicine
  • Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics, 2020, European Respiratory Journal
  • Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study), 2021, European Respiratory Journal
  • From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases, 2021, Allergy

Throughout their career, Elisabeth H. Bel has contributed extensively to understanding severe asthma and eosinophilic diseases by investigating biologic therapies and personalized treatment approaches.

They were recognized in 2018 as a member of Academia Europaea, indicating a form of professional acknowledgment within the academic community.

Best Publications

  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

  • Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

    Elisabeth H. Bel;Sally E. Wenzel;Philip J. Thompson;Charlene M. Prazma

  • Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

    J. K. Sont;L. N. A. Willems;E. H. Bel;J. H. J. M. Van Krieken

  • After asthma: redefining airways diseases

    Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson

  • Treatable traits: toward precision medicine of chronic airway diseases.

    Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier

  • The prevalence of severe refractory asthma

    Pieter-Paul W. Hekking;Reinier R. Wener;Marijke Amelink;Aelko H. Zwinderman

  • Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

    David Cheung;Mieke C. Timmers;Aeilko H. Zwinderman;Elisabeth H. Bel

  • Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

    Dominick E. Shaw;Ana R. Sousa;Stephen J. Fowler;Louise J. Fleming

  • Risk factors of frequent exacerbations in difficult-to-treat asthma

    ten A. Brinke;P.J. Sterk;A.A.M. Masclee;Ph. Spinhoven

  • An electronic nose in the discrimination of patients with asthma and controls

    Silvano Dragonieri;Robert Schot;Bart J.A. Mertens;Saskia Le Cessie

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • Factors associated with persistent airflow limitation in severe asthma.

    Anneke ten Brinke;Aeilko H. Zwinderman;Peter J. Sterk;Klaus F. Rabe

  • Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.

    Niki Fens;Aeilko H. Zwinderman;Marc P. van der Schee;Selma B. de Nijs

  • Chronic sinusitis in severe asthma is related to sputum eosinophilia.

    Anneke ten Brinke;Diana C. Grootendorst;Judith Th. Schmidt;Francisca T. de Bruïne

  • Severe asthma in adults: what are the important questions?

    Pascal Chanez;Sally E. Wenzel;Gary P. Anderson;Josep M. Anto

  • Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

    E.H. Bel;A. Sousa;L. Fleming;A. Bush

  • Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

    E. L. J. Van Rensen;K. C. M. Straathof;M. A. Veselic-Charvat;A. H. Zwinderman

  • Clinical phenotypes of asthma

    Elisabeth H. Bel

  • Adult-onset asthma: is it really different?

    Selma B. de Nijs;Lisette N. Venekamp;Elisabeth H. Bel

  • U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

    Diane Lefaudeux;Bertrand De Meulder;Matthew J. Loza;Nancy Peffer

  • "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.

    Anneke ten Brinke;Aeilko H. Zwinderman;Peter J. Sterk;Klaus F. Rabe

Frequent Co-Authors

Peter J. Sterk
Peter J. Sterk University of Amsterdam
René Lutter
René Lutter University of Amsterdam
Marc Humbert
Marc Humbert University of Paris-Saclay
Ratko Djukanovic
Ratko Djukanovic University of Southampton
Ian D. Pavord
Ian D. Pavord University of Oxford
David Price
David Price University of Aberdeen
Jørgen Vestbo
Jørgen Vestbo University of Manchester
Peter H. Howarth
Peter H. Howarth University of Southampton
Kian Fan Chung
Kian Fan Chung Imperial College London
Alvar Agusti
Alvar Agusti University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to various healthcare and research careers. For those interested in clinical practice, accelerated nursing paths like the easiest absn to get into offer a swift transition into nursing roles. These programs are designed for students with prior degrees who want to quickly enter the nursing workforce.

If you prefer a more hands-on clinical role with shorter training, consider exploring the fastest and easiest lpn programs. Licensed Practical Nurses play vital support roles in immunology-related patient care, especially in community and rehabilitation settings.

For advanced practice, the easiest fnp program options can help students become Family Nurse Practitioners. This path suits those aiming to combine immunology expertise with primary care delivery.

Mental health is another critical sector connected to immunology, especially regarding neuroinflammation and psychiatric conditions. The best online psychiatric mental health nurse practitioner programs provide a strong clinical foundation with high placement rates, supporting careers focused on integrative mental health care.

Best Scientists Citing Elisabeth H. Bel

Trending Scientists

Recently Published Articles